Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery.
J Control Release
; 352: 527-539, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36341933
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Experimental
/
Nanoparticles
Limits:
Animals
Language:
En
Journal:
J Control Release
Journal subject:
FARMACOLOGIA
Year:
2022
Type:
Article